Neel Mehta, MD
Interventional Pain Medicine · New York, NYNPI 1760641161
Payments from drug & device makers
Across 638 payments — averaging $1026.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$220K
- Boston Scientific$163K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$140K
- Vertex$35K
- GRT US Holding, Inc.$33K
- Averitas Pharma Inc.$26K
- plus $37K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 104 | $220,420 |
| Boston Scientific | 174 | $163,133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 135 | $139,858 |
| Vertex | 33 | $34,643 |
| GRT US Holding, Inc. | 44 | $33,025 |
| Averitas Pharma Inc. | 31 | $26,167 |
| Collegium Pharmaceutical, Inc. | 5 | $13,881 |
| Biodelivery Sciences International, Inc. | 15 | $12,233 |
| Medtronic(2 entities) | 30 | $3,057 |
| Abbott | 17 | $1,420 |
| Pacira Pharmaceuticals Incorporated | 3 | $1,076 |
| MML US, Inc. | 8 | $972 |
| Vertos Medical, Inc. | 2 | $813 |
| Relievant Medsystems, Inc. | 8 | $744 |
| Stryker | 1 | $500 |
| Alnylam Pharmaceuticals Inc. | 1 | $492 |
| Vertiflex, Inc. | 5 | $429 |
| Biotronik NRO, Inc. | 3 | $281 |
| Saluda Medical Americas, Inc. | 3 | $239 |
| Appliedvr Inc | 1 | $225 |
| Stratus Medical, LLC | 3 | $210 |
| AbbVie(2 entities) | 2 | $164 |
| Si-bone, Inc. | 2 | $164 |
| SPR Therapeutics, Inc | 2 | $149 |
| Nalu Medical, Inc. | 1 | $126 |
| Siemens Medical Solutions USA, Inc. | 1 | $93 |
| Foundation Fusion Solutions, LLC | 1 | $63 |
| Globus Medical | 1 | $55 |
| Almatica Pharma LLC | 2 | $44 |
How this compares
$654,674 in reported general payments places this provider in the 95th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in New York
- Corey HunterNew York$571K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
- Marco PappagalloNew York$36K
- Jason SieffermanNew York$29K
- Barthelemy LiabaudNew York$20K
- Devi NampiaparampilNew York$18K
- Jeffrey DeygooNew York$11K
- Imran PunekarNew York$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.